Literature DB >> 23331811

Cardiovascular recovery following bariatric surgery in extremely obese adolescents: preliminary results using Cardiac Magnetic Resonance (CMR) Imaging.

Marc P Michalsky1, Subha V Raman, Steven Teich, Dara P Schuster, John A Bauer.   

Abstract

PURPOSE: Baseline cardiovascular characteristics and longitudinal changes following weight loss surgery (WLS) in adolescents are not well defined. Recent data suggest that the use of transthoracic echocardiography (TTE) for preoperative cardiac assessment may provide suboptimal imaging fidelity secondary to excessive upper body adiposity. High fidelity imaging using cardiac magnetic resonance (CMR) is an extremely useful diagnostic tool. We report the use of CMR in a cohort of extremely obese adolescents undergoing WLS.
METHODS: A retrospective analysis of adolescent WLS patients at a single institution was conducted. Data collection included mean age, sex, body mass index (BMI), and CMR measurements of left ventricular (LV) mass, LV end-diastolic volume (LVEDV), ejection fraction (EF), and myocardial perfusion reserve index (MPRI). Comparison of CMR results to normative data derived from lean subjects was performed.
RESULTS: Ten subjects (9 female), with a mean age and BMI of 17.4 ± 1.9 years and 50.33 ± 10.21 kg/m(2) respectively, were studied. When compared to age, gender, and height matched normal weight (NW) controls, the obese (OB) subjects had evidence of increased LV mass (122 ± 25 g vs. 101 ± 10 g, OB vs. NW respectively, p<0.05), and increased LVEDV (156 ± 25 mL vs. 109 ± 9 mL, p<0.05), with an average EF of 61.5% ± 5% (range 52% to 67% vs. 71% to 74% expected EF for males and females, respectively, p=0.003). In addition, 60% of the OB subjects (6/10) demonstrated adenosine-induced sub-endocardial ischemia at baseline, the majority of whom underwent WLS (n=5) resulting in complete normalization of ischemia in 60% (3/5) and partial improvement in 40% (2/5). A reduction in mean LV mass (range 2 to 12 g) following WLS was observed.
CONCLUSION: Extreme adolescent obesity is associated with significant cardiovascular abnormalities that include LV hypertrophy (i.e. increased LV mass) and LV dilatation. These findings, considered to be well-recognized cardiovascular disease risk factors in adults, were shown to be reversible after WLS in the small group of subjects studied here. Additional large-scale investigations designed to examine obesity-related cardiovascular disease in severely obese adolescents are required.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23331811     DOI: 10.1016/j.jpedsurg.2012.10.032

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  13 in total

1.  Cardiovascular Risk Factors After Adolescent Bariatric Surgery.

Authors:  Marc P Michalsky; Thomas H Inge; Todd M Jenkins; Changchun Xie; Anita Courcoulas; Michael Helmrath; Mary L Brandt; Carroll M Harmon; Mike Chen; John B Dixon; Elaine M Urbina
Journal:  Pediatrics       Date:  2018-01-08       Impact factor: 7.124

Review 2.  Has the Time Come to Be More Aggressive With Bariatric Surgery in Obese Patients With Chronic Systolic Heart Failure?

Authors:  Amanda R Vest
Journal:  Curr Heart Fail Rep       Date:  2018-06

3.  Robotic vs. Laparoscopic Sleeve Gastrectomy in Adolescents; Reality or Hype.

Authors:  Victoria K Pepper; Terrence M Rager; Karen A Diefenbach; Mehul V Raval; Steven Teich; Marc P Michalsky
Journal:  Obes Surg       Date:  2016-08       Impact factor: 4.129

4.  Accuracy of the CNAP™ monitor, a noninvasive continuous blood pressure device, in providing beat-to-beat blood pressure measurements during bariatric surgery in severely obese adolescents and young adults.

Authors:  Joseph D Tobias; Chris McKee; Dan Herz; Steve Teich; Paul Sohner; Julie Rice; N'Diris Barry; Marc Michalsky
Journal:  J Anesth       Date:  2014-05-01       Impact factor: 2.078

5.  Should we target obesity in advanced heart failure?

Authors:  Amanda R Vest; James B Young
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-02

6.  Cardiovascular Risk Factors in Severely Obese Adolescents: The Teen Longitudinal Assessment of Bariatric Surgery (Teen-LABS) Study.

Authors:  Marc P Michalsky; Thomas H Inge; Mark Simmons; Todd M Jenkins; Ralph Buncher; Michael Helmrath; Mary L Brandt; Carroll M Harmon; Anita Courcoulas; Michael Chen; Mary Horlick; Stephen R Daniels; Elaine M Urbina
Journal:  JAMA Pediatr       Date:  2015-05       Impact factor: 16.193

Review 7.  ASMBS pediatric metabolic and bariatric surgery guidelines, 2018.

Authors:  Janey S A Pratt; Allen Browne; Nancy T Browne; Matias Bruzoni; Megan Cohen; Ashish Desai; Thomas Inge; Bradley C Linden; Samer G Mattar; Marc Michalsky; David Podkameni; Kirk W Reichard; Fatima Cody Stanford; Meg H Zeller; Jeffrey Zitsman
Journal:  Surg Obes Relat Dis       Date:  2018-03-23       Impact factor: 4.734

Review 8.  The Effects of Bariatric Surgery on Cardiac Structure and Function: a Systematic Review of Cardiac Imaging Outcomes.

Authors:  Ravi Aggarwal; Leanne Harling; Evangelos Efthimiou; Ara Darzi; Thanos Athanasiou; Hutan Ashrafian
Journal:  Obes Surg       Date:  2016-05       Impact factor: 4.129

9.  Adolescent bariatric surgery program characteristics: the Teen Longitudinal Assessment of Bariatric Surgery (Teen-LABS) study experience.

Authors:  Marc P Michalsky; Thomas H Inge; Steven Teich; Ihuoma Eneli; Rosemary Miller; Mary L Brandt; Michael Helmrath; Carroll M Harmon; Meg H Zeller; Todd M Jenkins; Anita Courcoulas; Ralph C Buncher
Journal:  Semin Pediatr Surg       Date:  2013-10-31       Impact factor: 2.754

10.  Changes in Functional Mobility and Musculoskeletal Pain After Bariatric Surgery in Teens With Severe Obesity: Teen-Longitudinal Assessment of Bariatric Surgery (LABS) Study.

Authors:  Justin R Ryder; Nicholas M Edwards; Resmi Gupta; Jane Khoury; Todd M Jenkins; Sharon Bout-Tabaku; Marc P Michalsky; Carroll M Harmon; Thomas H Inge; Aaron S Kelly
Journal:  JAMA Pediatr       Date:  2016-09-01       Impact factor: 16.193

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.